SD Biosensor Participates in Europe's Largest Clinical Microbiology Conference

ECCMID 2023

SD Biosensor announced on the 19th that it participated in 'ECCMID 2023,' the clinical microbiology conference held in Copenhagen, Denmark, from the 15th to the 18th.

On-site photos of SD Biosensor booth at ECCMID 2023.
[Photo by SD Biosensor]

The conference was attended by over 12,500 industry experts, including 245 pharmaceutical and bio companies, who presented research findings related to clinical microbiology and infectious diseases and promoted their companies through booth exhibitions.

Europe is a key market, accounting for 28% of the global in vitro diagnostics market. SD Biosensor expanded its participation scale compared to the previous year by operating a large standalone booth and conducting two symposiums.

At the first symposium, the company presented clinical results and the utility of the on-site molecular diagnostic platform Standard M10 for simultaneous diagnosis of influenza and COVID-19, as well as mpox detection, under the theme "Point-of-Care Diagnosis for Respiratory Infections and Mpox Detection." The second symposium focused on "The Role of Primary Stool Antigen Screening Tests for Diagnosing Gastrointestinal Infectious Diseases," presenting the usefulness of Helicobacter pylori antigen testing and urea breath tests using the fluorescent immunodiagnostic platform Standard F.

At the SD Biosensor standalone booth, a tunnel-shaped exhibition space was set up under the themes "The Utility of M10 During the COVID-19 Pandemic" and "The Technology of M10." Additionally, there was a display area for eight cartridges, the soon-to-be-launched fluorescent immunodiagnostic mycoplasma antigen and antibody products, and a continuous glucose monitoring system (CGMS) scheduled for release in 2024.

SD Biosensor emphasized that it operated the booth together with its three European subsidiaries: the German, Italian, and Spanish branches. David Stammel, CEO of the German subsidiary, said, "It was a great opportunity to showcase SD Biosensor's strengths not only in COVID-19 diagnostics but also in major infectious diseases and routine testing." He added, "The academic symposiums held during the conference were successfully concluded with many attendees and great interest."

This content was produced with the assistance of AI translation services.